|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
2.200 +0.040 (+1.852%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.67
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 14.29 RMB (cts) | |
| Net Profit | 532.61 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 803.80 | 22.00 | 0 | -- | 843.00 | 683.00 |
| 2025 | 885.00 | 25.00 | 0 | -- | 1,000.00 | 840.80 |
| 2026 | 1,038.00 | 29.00 | 0 | -- | 1,309.00 | 895.70 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 843.00 | 23.00 | -- | CITIGROUP | Buy | 4.00 | 30/08/2024 | |
| 2024 | 803.80 | 22.00 | -- | ZHONGTAI INT'L SEC | Buy | 2.90 | 17/12/2024 | |
| 2024 | 683.00 | 19.00 | -- | MORGAN STANLEY | Underweight | 2.80 | 29/08/2024 | |
| 2025 | 1,000.00 | 27.00 | -- | CITIGROUP | -- | -- | 30/08/2024 | |
| 2025 | 840.80 | 23.00 | -- | ZHONGTAI INT'L SEC | -- | -- | 17/12/2024 | |
| 2025 | 885.00 | 25.00 | -- | MORGAN STANLEY | -- | -- | 29/08/2024 | |
| 2026 | 1,309.00 | 35.00 | -- | CITIGROUP | -- | -- | 30/08/2024 | |
| 2026 | 895.70 | 24.00 | -- | ZHONGTAI INT'L SEC | -- | -- | 17/12/2024 | |
| 2026 | 1,038.00 | 29.00 | -- | MORGAN STANLEY | -- | -- | 29/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/12/2024 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 387,836 |
| %Change | 158.597% |
| EPS / (LPS) | RMB 0.103 |
| NBV Per Share (¥) | RMB 3.461 |